Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

S&U maintains 'faith and confidence'

(Sharecast News) - Motor and property finance business S&U said on Tuesday that it was optimistic about the new trading year, although it also acknowledged that challenges remain. S&U said its Advantage Finance unit, which provides car finance, has seen transaction volumes start to improve after a tough period. It also noted that restrictions imposed by a regulatory investigation into alleged misselling had now eased, with new deals rising to more than 900 in January.

Loan collections hit 87% in the year ended 31 January, up from a cumulative 85% in the prior year.

S&U also stated that while certain challenges remained, including outstanding non-paying customer cases, it was working on digital improvements and stronger customer outreach to get operations back on track.

S&U added that Aspen Bridging, its property finance division, delivered a record-breaking year, with net receivables growing 17% to £152.0m and loan repayments and recoveries jumping 25% year-on-year. Transaction volumes were 16% higher, with an average deal size of more than £900,000.

Chairman Anthony Coombs said: "Over the past year, macroeconomic and regulatory pressures on the business have severely tested S&U's historic experience, expertise and resilience. Despite these, we maintain our faith and confidence in the service we are proud to give to our loyal customers.

"As a more pro-growth national agenda develops and the regulatory frenzy eases, then this provides a solid base for a return to more normal levels of profitability, growth and returns for our shareholders."

As of 0955 GMT, S&U shares were down 3.70% at 1,569.75p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.